Table 8.
Level of IgE in peripheral blood as a measure of CVA.
| Study or subgroup | Mean | Experimental | Mean | Control | Weight | Mean difference | ||
|---|---|---|---|---|---|---|---|---|
| SD | Total | SD | Total | IV, fixed, 95% CI | ||||
| Li Qiaoxiang 2017 | 119.33 | 79.63 | 60 | 167.94 | 89.23 | 60 | 8.8% | -48.61 [-78.87, -18.35] |
| Ma Ying 2018 | 131.2 | 26.4 | 66 | 189.3 | 31.7 | 66 | 81.2% | -58.10 [-68.05, -48.15] |
| Xue Ming 2018 | 124.24 | 112.45 | 45 | 171.58 | 112.99 | 45 | 3.7% | -47.34 [-93.92, -0.76] |
| Zhang Xiaoyan 2014 | 136.61 | 115.56 | 50 | 158.94 | 127.27 | 46 | 3.4% | -22.33 [-71.10, 26.44] |
| Zhao Qi 2018 | 134.61 | 117.61 | 42 | 156.49 | 124.88 | 42 | 3.0% | -21.88 [-73.76, 30.00] |
| Total (95% CI) | 263 | 259 | 100% | -54.58 [-63.54, -45.61] | ||||
Heterogeneity: chi2 = 3.93; df = 4 (P = 0.42); I2 = 0%. Test for overall effect: Z = 11.93 (P < 0.00001).